Literature DB >> 17407521

The role of the urothelium in mediating bladder responses to isoprenaline.

Shigetaka Murakami1, Christopher R Chapple, Hironobu Akino, Donna J Sellers, Russell Chess-Williams.   

Abstract

OBJECTIVES: To investigate whether the responses of the pig bladder to isoprenaline (a nonselective beta-adrenoceptor agonist) are influenced by the presence of an intact urothelium and whether any influence might be attributed to the release of nitric oxide (NO), since stimulation of beta-adrenoceptors induces a direct relaxation of detrusor smooth muscle and beta-adrenoceptors are also present on the urothelium.
MATERIAL AND METHODS: Paired (in the presence or absence of urothelium) longitudinal strips of pig bladder dome were set up in tissue baths and the developed tension recorded. Relaxation responses to isoprenaline were examined after pre-contraction with carbachol. The inhibitory effects of isoprenaline were examined by comparing responses to carbachol in the absence and presence of isoprenaline. To examine a possible role for NO, similar experiments were performed in the presence of the NO synthase inhibitor N(G)-nitro-L-arginine (L-NNA).
RESULTS: In the presence of the urothelium, both the potency (pEC(50)) and the maximum contractile responses to carbachol were depressed. In relaxation experiments, isoprenaline relaxed carbachol pre-contracted tissues by approximately 75%, and the potency and maximum relaxation were similar in the absence and presence of the urothelium. In the inhibition experiments, the presence of isoprenaline caused rightward parallel shifts of the concentration-response curves to carbachol, but isoprenaline did not influence the maximum contractions. In the presence of the urothelium there was a greater shift with 0.1 microm isoprenaline than in denuded tissues. Incubation with L-NNA did not affect the influence of the urothelium on responses to isoprenaline in any experimental group.
CONCLUSIONS: The relaxation responses of the bladder to isoprenaline do not appear to involve the urothelium or NO release in vitro. However, contractile responses to carbachol were inhibited in the presence of an intact urothelium, and this might reflect the release of an inhibitory factor other than NO.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17407521     DOI: 10.1111/j.1464-410X.2006.06679.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  19 in total

1.  Unique properties of muscularis mucosae smooth muscle in guinea pig urinary bladder.

Authors:  Thomas J Heppner; Jeffrey J Layne; Jessica M Pearson; Hagop Sarkissian; Mark T Nelson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-01       Impact factor: 3.619

2.  Functional investigation of β-adrenoceptors in human isolated detrusor focusing on the novel selective β3-adrenoceptor agonist KUC-7322.

Authors:  Yasuhiko Igawa; Tim Schneider; Yoshinobu Yamazaki; Satoshi Tatemichi; Yukio Homma; Osamu Nishizawa; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-29       Impact factor: 3.000

3.  Expression and functional role of beta-adrenoceptors in the human urinary bladder urothelium.

Authors:  Atsushi Otsuka; Hitoshi Shinbo; Rikiya Matsumoto; Yutaka Kurita; Seiichiro Ozono
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-03-01       Impact factor: 3.000

4.  Urothelial beta-3 adrenergic receptors in the rat bladder.

Authors:  F Aura Kullmann; Thomas R Downs; Debra E Artim; Brian J Limberg; Mansi Shah; Dan Contract; William C de Groat; Jan S Rosenbaum
Journal:  Neurourol Urodyn       Date:  2011-01       Impact factor: 2.696

Review 5.  Modulation of lower urinary tract smooth muscle contraction and relaxation by the urothelium.

Authors:  Donna Sellers; Russ Chess-Williams; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-05-28       Impact factor: 3.000

Review 6.  Urothelial signaling.

Authors:  Lori Birder; Karl-Erik Andersson
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

Review 7.  Clinical use of the β3 adrenoceptor agonist mirabegron in patients with overactive bladder syndrome.

Authors:  Monika Vij; Marcus J Drake
Journal:  Ther Adv Urol       Date:  2015-10

Review 8.  Urothelial signaling.

Authors:  Lori A Birder
Journal:  Auton Neurosci       Date:  2009-08-08       Impact factor: 3.145

9.  Involvement of TRPM4 in detrusor overactivity following spinal cord transection in mice.

Authors:  F Aura Kullmann; Jonathan M Beckel; Bronagh McDonnell; Christian Gauthier; Andrew M Lynn; Amanda Wolf-Johnston; Anthony Kanai; Irina V Zabbarova; Youko Ikeda; William C de Groat; Lori A Birder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-07-27       Impact factor: 3.000

10.  β-Adrenoceptor-mediated differences in transverse and longitudinal strips from the rat detrusor.

Authors:  Willmann Liang; Wan Ning Lo
Journal:  Int Urol Nephrol       Date:  2010-05-21       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.